Acute Myeloid Leukemia: An Ever-Changing Disease

Acute myeloid leukemia is the most common form of acute leukemia in adults. In recent years, there has been robust characterization of molecular targets for drug development, leading to the U.S. Food & Drug Administration approval of numerous new treatments during 2017 and 2018. In light of thes...

Descripción completa

Detalles Bibliográficos
Autores principales: Nix, Nancy M., Price, Allyson
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2019
Materias:
Introduction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521118/
http://dx.doi.org/10.6004/jadpro.2019.10.8.12
Descripción
Sumario:Acute myeloid leukemia is the most common form of acute leukemia in adults. In recent years, there has been robust characterization of molecular targets for drug development, leading to the U.S. Food & Drug Administration approval of numerous new treatments during 2017 and 2018. In light of these new approvals, this article provides an update for advanced practitioners on risk stratification, which is critical for guiding treatment selection.

Ejemplares similares